ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2020
Comparing GPS-Based Community Mobility Measures with Self-report Assessments in Older Adults with Parkinson's Disease.
Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04953637 (Combined Physiotherapy and Deep Brain Stimulation to Improve Independent Community Mobility in Parkinson's Disease), which is not on this map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Combined Physiotherapy and Deep Brain Stimulation to Improve Independent Community Mobility in Parkinson's Disease
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Wearable and Portable GPS Solutions for Monitoring Mobility in Dementia: A Systematic Review.Sensors (Basel, Switzerland) · 2022Pooled it
- Wearable GPS and Accelerometer Technologies for Monitoring Mobility and Physical Activity in Neurodegenerative Disorders: A Systematic Review.Sensors (Basel, Switzerland) · 2021Pooled it
- Are Mobile Persons With Parkinson Disease Necessarily More Active?Journal of neurologic physical therapy : JNPT · 2021Trial
- Integrating GPS and Accelerometry to Capture Life-Space Mobility in Parkinson's Disease.Sensors (Basel, Switzerland) · 2026Article
- Semi-Automated Processing of Harmonized Accelerometer and GPS Data in R:Sensors (Basel, Switzerland) · 2025Article
- Article
- Assessing the clinical utility of inertial sensors for home monitoring in Parkinson's disease: a comprehensive review.NPJ Parkinson's disease · 2024Article
- [What importance does outpatient care have for mobility in rural areas? Results from a GPS study among persons aged 75 and older].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024Article
- Smartphone Global Positioning System-Based System to Assess Mobility in Health Research: Development, Accuracy, and Usability Study.JMIR rehabilitation and assistive technologies · 2023Article
- Community mobility and participation assessment of manual wheelchair users: a review of current techniques and challenges.Frontiers in human neuroscience · 2023Review
- Mapping the Way to Good Health: The Interdisciplinary Challenges of Geographers in Medical Research.International journal of environmental research and public health · 2022Article
- Life-Space Mobility and Parkinson's Disease. A Multiple-Methods Study.Movement disorders clinical practice · 2022Article
- Mobility enhancement among older adults 75 + in rural areas: Study protocol of the MOBILE randomized controlled trial.BMC geriatrics · 2022Article
- How Long Should GPS Recording Lengths Be to Capture the Community Mobility of An Older Clinical Population? A Parkinson's Example.Sensors (Basel, Switzerland) · 2022Article
- Comparisons Between GPS-based and Self-reported Life-space Mobility in Older Adults.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2022Article
- The development and validation of a prototype mobility tracker for assessing the life space mobility and activity participation of older adults.BMC geriatrics · 2020Article
- Effects of lighting variability on locomotion in posterior cortical atrophy.Alzheimer's & dementia (New York, N. Y.) · 2020Article
- Wearable sensors and features for diagnosis of neurodegenerative diseases: A systematic review.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundReal-life community mobility (CM) measures for older adults, especially those with Parkinson's disease (PD), are important tools when helping individuals maintain optimal function and quality of life. This is one of the first studies to compare an objective global positioning system (GPS) sensor and subjective self-report CM measures in an older clinical population.
methodsOver 14 days, 54 people in Ontario, Canada with early to mid-stage PD (mean age = 67.5 ± 6.3 years; 47 men; 46 retired) wore a wireless inertial measurement unit with GPS (WIMU-GPS), and completed the Life Space Assessment and mobility diaries. We assessed the convergent validity, reliability and agreement on mobility outcomes using Spearman's correlation, intraclass correlation coefficient, and Bland-Altman analyses, respectively.
resultsConvergent validity was attained by the WIMU-GPS for trip frequency (rs = .69, 95% confidence interval [CI] = 0.52-0.81) and duration outside (rs = .43, 95% CI = 0.18-0.62), but not for life space size (rs = .39, 95% CI = 0.14-0.60). The Life Space Assessment exhibited floor and ceiling effects. Moderate agreements were observed between WIMU-GPS and diary for trip frequency and duration (intraclass correlation coefficients = 0.71, 95% CI = 0.51-0.82; 0.67, 95% CI = 0.42-0.82, respectively). Disagreement was more common among nonretired individuals.
conclusionsWIMU-GPS could replace diaries for trip frequency and duration assessments in older adults with PD. Both assessments are best used for retired persons. However, the Life Space Assessment may not reflect actual mobility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.